ClinicalTrials.gg
RecruitingNCT06580158Updated Mar 4, 2026

AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

An observational study in Aortic Stenosis and Diastolic Dysfunction, sponsored by Mayo Clinic. Recruiting at 1 site in United States. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-03-04.

Sponsored by Mayo Clinic · Observational

How we know

From the registry’s dates

  • Started Nov 2024; still recruiting 2 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,000
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 189 studies in Aortic Valve Stenosis with a site in United States — 43 open to participants now, 67 under way, 3 of them phase 3. Aortic Valve Stenosis · United States.

Planned enrollment
8th of 64
2,000 · median 102
Started
2024
with 12 others
Observational
64 of 189
16 open now
Primary completion
2027-03
later than 33 of 66 live
Registered
163rd of 189
by date
Lead sponsor
6 of 189
Mayo Clinic

Among the 189 studies in Aortic Valve Stenosis with a site in United States, this one is the 8th largest by planned enrollment of the 64 observational ones that give a count, is one of 13 that started in 2024, is one of 64 observational ones, reaches primary completion later than 33 of the 66 other live ones, and was the 163rd registered.

Aortic Valve Stenosis

1,028 studies on the registry are indexed under Aortic Valve Stenosis; 295 are open to participants now.

Browse Aortic Valve Stenosis studies →

Open to participants now

43 of the 189 studies in Aortic Valve Stenosis with a site in United States are open now. Recruiting first, the newest first:

37 more — sign in →

All 43 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 209 Aortic Valve Stenosis studies recruiting now, 163 (78%) set no upper age limit and 9 (4%) stop at 75 or younger; 24 take children under 18; 14 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 189 studies in Aortic Valve Stenosis with a site in United States, or all of them as a file.
02

Study summary

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

03

Conditions studied

  • Aortic Stenosis
  • Diastolic Dysfunction
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥ 60 years of age must have a clinical scheduled performed.

Exclusion criteria

Exclusion Criteria:

  • \< 59 years of age
  • Is not scheduled for a clinical
  • Unable to provide consent.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Patients who are completing an outpatient electrocardiogram (ECG) at the Mayo Clinic.

    Device: AI-ECG Dashboard · Diagnostic Test: Point of care ultrasound (POCUS)

Interventions

  • DeviceAI-ECG Dashboard

    Patients standard of care ECG's will be processed through the AI-ECG Dashboard

  • Diagnostic testPoint of care ultrasound (POCUS)

    Patients will undergo a ultrasound to confirm diagnosis of atrial stenosis or diastolic dysfunction.

06

What researchers measure

Primary outcomes

  1. Number of patients with positive AI-ECG

    Positive AI-ECG will be determined by the sensitivity, specificity, positive predictive value, and negative predictive value.

    Time frame: Baseline

  2. Number of studies with reasonable image quality in patients with positive AI-ECG

    Image quality will be determined by sonographers at the time of imaging and will be scored on a scale from 1-4: 1. Excellent , sufficient for publication 2. Good, sufficient for data analysis 3. Fair, just enough for data analysis without complete views 4. Poor, not usable for data analysis

    Time frame: Baseline

Secondary outcomes

  1. Number of times the AI ECG and TTE (transthoracic echocardiogram) are statistically comparative

    Will be compared using parametric (2-sample t-test) and non-parametric tests (Wilcoxon rank sum test) for continuous variables, and the χ2 test or Fisher exact test for nominal variables. A p-value of \< 0.05 will be categorized as significant for the statistical analysis

    Time frame: Baseline

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2024 (actual). Primary completion is estimated for Mar 2027, 28 months after the start.

Of 206 non-industry observational studies under Aortic Valve Stenosis, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 120. This study's planned 28 months is below that.

Counting every sponsor, half of 243 studies reached it within 44 months; a quarter within 23 and three quarters within 86.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2024
First posted
Aug 30, 2024
StartActual
Nov 8, 2024
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Mar 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06580158
Lead sponsor
Mayo Clinic
Responsible party
Jae K. Oh, M.D. (Principal Investigator, Mayo Clinic) — Principal investigator
First posted
Aug 30, 2024
Start date
Nov 8, 2024
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Mar 4, 2026

Study contacts

Brian Rudquist
Contact
Rudquist.Brian@mayo.edu
(507) 538-5146
Jae Oh, M.D.
Contact
oh.jae@mayo.edu
Jae Oh, M.D.
principal investigator · Mayo Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion